Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
SAGE Therapeutics (SAGE)
NASDAQ:SAGE
SAGE Therapeutics (SAGE) Stock Forecast & Price Target
873 Followers
See the Price Targets and Ratings of:
SAGE Analyst Ratings
Hold
3 Buy
14 Hold
2 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SAGE Stock 12 Month Forecast
Average Price Target
$18.00
▲(66.36% Upside)
| Highest Price Target$25.00 | Average Price Target$18.00 | Lowest Price Target$8.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
H.C. Wainwright
Reiterated
07/02/24
Robert W. Baird
Reiterated
06/11/24
Mizuho Securities
Reiterated
06/11/24
Bank of America Securities
Reiterated
06/11/24
Morgan Stanley
$22
Hold
103.33%
Upside
Reiterated
06/11/24
Cautious Optimism for SAGE Therapeutics' Dalzanemdor Amid Pending Clinical Trials
Truist Financial
$22→$18
Hold
66.36%
Upside
Reiterated
04/26/24
Hold Rating on SAGE Therapeutics Amid Limited Revenue Prospects and Pipeline Uncertainty
Goldman Sachs
$28→$19
Hold
75.60%
Upside
Reiterated
04/26/24
Sage Therapeutics (SAGE) PT Lowered to $19 at Goldman SachsGoldman Sachs analyst Salveen Richter lowered the price target on Sage Therapeutics (NASDAQ: SAGE) to $19.00 (from $28.00) while maintaining a Neutral rating.
RBC Capital
$26→$15
Hold
38.63%
Upside
Reiterated
04/25/24
SAGE Therapeutics (SAGE) Receives a Hold from RBC Capital
Stifel Nicolaus
$20
Hold
84.84%
Upside
Reiterated
04/25/24
Analysts Offer Insights on Healthcare Companies: Lisata Therapeutics (NASDAQ: LSTA) and SAGE Therapeutics (NASDAQ: SAGE)
Best Analysts Covering SAGE Therapeutics
Which Analyst Should I Follow If I Want to Buy SAGE and Sell After:
1 Month
3 Months
1 Year
Success Rate
7/17 ratings generated profit
Average Return
-8.62%
reiterated a sell rating 22 days ago
Copying Tazeen Ahmad's trades and holding each position for 1 Year would result in 41.18% of your transactions generating a profit, with an average return of -8.62% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SAGE Analyst Recommendation Trends
Rating
Feb 24
Mar 24
Apr 24
May 24
Jun 24
Strong Buy
0
1
2
3
5
Buy
6
6
7
3
3
Hold
17
17
33
24
29
Sell
0
0
2
4
6
Strong Sell
0
0
0
0
0
total
23
24
44
34
43
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
SAGE Financial Forecast
SAGE Stock Forecast FAQ
What is SAGE’s average 12-month price target, according to analysts?
Based on analyst ratings, SAGE Therapeutics’s 12-month average price target is $18.00.
What is SAGE’s upside potential, based on the analysts’ average price target?
SAGE Therapeutics has 66.36% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SAGE a Buy, Sell or Hold?
SAGE Therapeutics has a consensus rating of Hold which is based on 3 buy ratings, 14 hold ratings and 2 sell ratings.
What is SAGE Therapeutics’s price target?
The average price target for SAGE Therapeutics is $18.00. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $25.00 ,the lowest forecast is $8.00. The average price target represents 66.36% Increase from the current price of $10.82.
The highest analyst price target is $25.00 ,the lowest forecast is $8.00. The average price target represents 66.36% Increase from the current price of $10.82.
What do analysts say about SAGE Therapeutics?
SAGE Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 19 Wall Streets Analysts.
How can I buy shares of SAGE?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.